A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors

Summary

The goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of ES009 administered intravenously to subjects with advanced solid tumors.

Timeline

Start

2023-09-26

Primary completion

2025-02-18

Completion

2025-02-18

Drugs

Indications